PL2303846T3 - Podstawione izochinoliny i izochinolinony jako inhibitory kinazy Rho - Google Patents

Podstawione izochinoliny i izochinolinony jako inhibitory kinazy Rho

Info

Publication number: PL2303846T3
Authority: PL; Poland
Prior art keywords: isoquinolinones; kinase inhibitors; rho kinase; substituted isoquinolines; isoquinolines
Prior art date: 2008-06-24

Application number

PL09768949T

Other languages

English (en)

Inventor

Oliver Plettenburg

Katrin Lorenz

John Weston

Matthias Loehn

Heinz-Werner Kleemann

Olivier Duclos

Frédéric Jeannot

Original Assignee

Sanofi Sa

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2008-06-24

Filing date

2009-06-19

Publication date

2015-10-30

2009-06-19 Application filed by Sanofi Sa filed Critical Sanofi Sa

2015-10-30 Publication of PL2303846T3 publication Critical patent/PL2303846T3/pl

Links

VDBNYAPERZTOOF-UHFFFAOYSA-N isoquinolin-1(2H)-one Chemical class C1=CC=C2C(=O)NC=CC2=C1 VDBNYAPERZTOOF-UHFFFAOYSA-N 0.000 title 1
150000002537 isoquinolines Chemical class 0.000 title 1
239000003590 rho kinase inhibitor Substances 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
- C07D217/22—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
- C07D217/24—Oxygen atoms
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives

Landscapes

Health & Medical Sciences (AREA)
Organic Chemistry (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Diabetes (AREA)
Cardiology (AREA)
Neurosurgery (AREA)
Neurology (AREA)
Biomedical Technology (AREA)
Hematology (AREA)
Urology & Nephrology (AREA)
Endocrinology (AREA)
Heart & Thoracic Surgery (AREA)
Obesity (AREA)
Pulmonology (AREA)
Pain & Pain Management (AREA)
Ophthalmology & Optometry (AREA)
Oncology (AREA)
Hospice & Palliative Care (AREA)
Reproductive Health (AREA)
Virology (AREA)
Communicable Diseases (AREA)
Tropical Medicine & Parasitology (AREA)
Gynecology & Obstetrics (AREA)
Molecular Biology (AREA)
Psychiatry (AREA)
Emergency Medicine (AREA)
Rheumatology (AREA)
Gastroenterology & Hepatology (AREA)

PL09768949T 2008-06-24 2009-06-19 Podstawione izochinoliny i izochinolinony jako inhibitory kinazy Rho PL2303846T3 (pl)

Applications Claiming Priority (4)

Application Number	Priority Date	Filing Date	Title
EP08290606		2008-06-24
US15314909P	2009-02-17	2009-02-17
EP20090768949 EP2303846B1 (en)	2008-06-24	2009-06-19	Substituted isoquinolines and isoquinolinones as rho kinase inhibitors
PCT/EP2009/004421 WO2009156100A1 (en)	2008-06-24	2009-06-19	Substituted isoquinolines and isoquinolinones as rho kinase inhibitors

Publications (1)

Publication Number	Publication Date
PL2303846T3 true PL2303846T3 (pl)	2015-10-30

Family

ID=40049863

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PL09768949T PL2303846T3 (pl)	2008-06-24	2009-06-19	Podstawione izochinoliny i izochinolinony jako inhibitory kinazy Rho

Country Status (32)

Country	Link
US (1)	US8541449B2 (pl)
EP (1)	EP2303846B1 (pl)
JP (1)	JP5713893B2 (pl)
KR (1)	KR101638326B1 (pl)
CN (1)	CN102131784B (pl)
AR (1)	AR072281A1 (pl)
AU (1)	AU2009262517B2 (pl)
BR (1)	BRPI0914696A2 (pl)
CA (1)	CA2728137C (pl)
CO (1)	CO6321250A2 (pl)
CR (1)	CR11831A (pl)
DK (1)	DK2303846T3 (pl)
DO (1)	DOP2010000394A (pl)
EC (1)	ECSP10010705A (pl)
ES (1)	ES2541827T3 (pl)
HR (1)	HRP20150726T1 (pl)
HU (1)	HUE026617T2 (pl)
IL (1)	IL210113A (pl)
MA (1)	MA32400B1 (pl)
MX (1)	MX2010013975A (pl)
MY (1)	MY157330A (pl)
NZ (1)	NZ590070A (pl)
PE (1)	PE20110059A1 (pl)
PL (1)	PL2303846T3 (pl)
PT (1)	PT2303846E (pl)
RU (1)	RU2538588C2 (pl)
SI (1)	SI2303846T1 (pl)
SV (1)	SV2010003772A (pl)
TW (1)	TWI462907B (pl)
UY (1)	UY31925A (pl)
WO (1)	WO2009156100A1 (pl)
ZA (1)	ZA201008119B (pl)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AU2009262516B8 (en) *	2008-06-24	2014-01-30	Sanofi	6-substituted isoquinolines and isoquinolinones
EP3495366A1 (en)	2011-07-15	2019-06-12	Shionogi & Co., Ltd	Azabenzimidazole derivative having ampk-activating activity
WO2013113716A1 (en)	2012-02-03	2013-08-08	Basf Se	Fungicidal pyrimidine compounds
US9055750B2 (en)	2012-02-03	2015-06-16	Basf Se	Fungicidal pyrimidine compounds
US9072301B2 (en)	2012-02-03	2015-07-07	Basf Se	Fungicidal pyrimidine compounds
WO2013113791A1 (en)	2012-02-03	2013-08-08	Basf Se	Fungicidal pyrimidine compounds
WO2013113773A1 (en)	2012-02-03	2013-08-08	Basf Se	Fungicidal pyrimidine compounds
WO2013113776A1 (en)	2012-02-03	2013-08-08	Basf Se	Fungicidal pyrimidine compounds
WO2013113720A1 (en)	2012-02-03	2013-08-08	Basf Se	Fungicidal pyrimidine compounds
US9738642B2 (en)	2013-09-19	2017-08-22	Bristol-Myers Squibb Company	Triazolopyridine ether derivatives and their use in neurological and pyschiatric disorders
FR3017868A1 (fr)	2014-02-21	2015-08-28	Servier Lab	Derives d'isoquinoleine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
JP6883173B2 (ja)	2015-05-12	2021-06-09	ヘモストッドエスエー	改善された血小板産生のための薬理学的特徴およびマイクロ流体特徴の組み合わせ
WO2018228452A1 (zh)	2017-06-16	2018-12-20	成都先导药物开发有限公司	一种抑制 rock 的化合物及其用途
CN109810174B (zh) *	2017-11-21	2021-01-01	首都医科大学	异喹啉-3-甲酰-TARGD(aa)aa,其制备,抗静脉血栓活性和应用
CN110317169B (zh) *	2018-03-29	2022-06-03	复旦大学	一种1-取代异喹啉酮化合物及其制备方法
US11738030B2 (en)	2021-10-30	2023-08-29	Aneuryst, Inc.	Treatments for disturbed cerebral homeostasis

Family Cites Families (55)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE2702600A1 (de) *	1977-01-22	1978-07-27	Thomae Gmbh Dr K	Neue aminoalkoxyphenyl-derivate
FR2485537B2 (fr)	1977-04-13	1986-05-16	Anvar	Dipyrido(4,3-b)(3,4-f)indoles, procede d'obtention, application therapeutique et compositions pharmaceutiques les contenant
JPH06501921A (ja)	1990-07-31	1994-03-03	イー・アイ・デュポン・ドウ・ヌムール・アンド・カンパニー	選択されたハロカーボンの触媒平衡化
US5480883A (en)	1991-05-10	1996-01-02	Rhone-Poulenc Rorer Pharmaceuticals Inc.	Bis mono- and bicyclic aryl and heteroaryl compounds which inhibit EGF and/or PDGF receptor tyrosine kinase
GB9516709D0 (en)	1995-08-15	1995-10-18	Zeneca Ltd	Medicament
ZA9610741B (en)	1995-12-22	1997-06-24	Warner Lambert Co	4-Substituted piperidine analogs and their use as subtype selective nmda receptor antagonists
ATE359822T1 (de)	1996-08-12	2007-05-15	Mitsubishi Pharma Corp	Medikamente enthaltend rho-kinase inhibitoren
JPH1087629A (ja)	1996-09-18	1998-04-07	Fujisawa Pharmaceut Co Ltd	新規イソキノリン誘導体、およびその医薬用途
US6362191B1 (en)	1997-08-29	2002-03-26	Zeneca Ltd.	Aminometyl oxooxazolidinyl benzene derivatives
TW575567B (en) *	1998-10-23	2004-02-11	Akzo Nobel Nv	Serine protease inhibitor
GB9912701D0 (en)	1999-06-01	1999-08-04	Smithkline Beecham Plc	Novel compounds
US6541456B1 (en)	1999-12-01	2003-04-01	Isis Pharmaceuticals, Inc.	Antimicrobial 2-deoxystreptamine compounds
WO2001053288A1 (en)	2000-01-20	2001-07-26	Eisai Co., Ltd.	Novel piperidine compounds and drugs containing the same
US7217722B2 (en)	2000-02-01	2007-05-15	Kirin Beer Kabushiki Kaisha	Nitrogen-containing compounds having kinase inhibitory activity and drugs containing the same
AU2001239947A1 (en)	2000-02-29	2001-09-12	Curis, Inc.	Methods and compositions for regulating adipocytes
GB0004887D0 (en)	2000-03-01	2000-04-19	Astrazeneca Uk Ltd	Chemical compounds
AR033517A1 (es)	2000-04-08	2003-12-26	Astrazeneca Ab	Derivados de piperidina, proceso para su preparacion y uso de estos derivados en la fabricacion de medicamentos
GB0013060D0 (en)	2000-05-31	2000-07-19	Astrazeneca Ab	Chemical compounds
AU2001296008A1 (en)	2000-10-27	2002-05-06	Takeda Chemical Industries Ltd.	Process for preparing substituted aromatic compounds and intermediates therefor
US20040077654A1 (en)	2001-01-15	2004-04-22	Bouillot Anne Marie Jeanne	Aryl piperidine and piperazine derivatives as inducers of ldl-receptor expression
SE0101038D0 (sv)	2001-03-23	2001-03-23	Astrazeneca Ab	Novel compounds
WO2002088101A2 (en)	2001-04-27	2002-11-07	Vertex Pharmaceuticals Incorporated	Inhibitors of bace
US7199147B2 (en)	2001-06-12	2007-04-03	Dainippon Sumitomo Pharma Co., Ltd.	Rho kinase inhibitors
GB0117899D0 (en)	2001-07-23	2001-09-12	Astrazeneca Ab	Chemical compounds
CA2458009C (en)	2001-08-24	2011-08-16	Yale University	Piperazinone compounds as anti-tumor and anti-cancer agents and methods of treatment
WO2003024450A1 (en)	2001-09-20	2003-03-27	Eisai Co., Ltd.	Methods for treating prion diseases
SE0104340D0 (sv)	2001-12-20	2001-12-20	Astrazeneca Ab	New compounds
AU2003281623B8 (en) *	2002-07-22	2009-06-11	Asahi Kasei Pharma Corporation	5-substituted isoquinoline derivative
CA2502583A1 (en)	2002-09-12	2004-03-25	Kirin Beer Kabushiki Kaisha	Isoquinoline derivatives having kinase inhibitory activity and medicament containing the same
WO2004105757A2 (en)	2003-05-29	2004-12-09	Schering Aktiengesellschaft	Use of rho-kinase inhibitors in the treatment of aneurysm and cardiac hypertrophy
US20070021404A1 (en)	2003-06-24	2007-01-25	Dan Peters	Novel aza-ring derivatives and their use as monoamine neurotransmitter re-uptake inhibitors
JP4794446B2 (ja)	2003-09-23	2011-10-19	メルク・シャープ・エンド・ドーム・コーポレイション	イソキノリン系カリウムチャンネル阻害薬
WO2005030791A2 (en)	2003-09-23	2005-04-07	Merck & Co., Inc.	Isoquinolinone potassium channel inhibitors
US20050067037A1 (en)	2003-09-30	2005-03-31	Conocophillips Company	Collapse resistant composite riser
WO2005035516A1 (ja)	2003-10-10	2005-04-21	Ono Pharmaceutical Co., Ltd.	新規縮合複素環化合物およびその用途
JP2007008816A (ja) *	2003-10-15	2007-01-18	Ube Ind Ltd	新規イソキノリン誘導体
US7449477B2 (en)	2003-11-25	2008-11-11	Eli Lilly And Company	7-phenyl-isoquinoline-5-sulfonylamino derivatives as inhibitors of akt (protein kinase B)
WO2005074535A2 (en)	2004-01-30	2005-08-18	Eisai Co., Ltd.	Cholinesterase inhibitors for spinal cord disorders
US20080312189A1 (en)	2004-03-05	2008-12-18	Eisai Co., Ltd.	Cadasil Treatment with Cholinesterase Inhibitors
SE0400850D0 (sv)	2004-03-30	2004-03-31	Astrazeneca Ab	Novel Compounds
US7517991B2 (en)	2004-10-12	2009-04-14	Bristol-Myers Squibb Company	N-sulfonylpiperidine cannabinoid receptor 1 antagonists
PT1899322E (pt)	2005-06-28	2009-11-09	Sanofi Aventis	Derivados de isoquinolina como inibidores de rho-cinase
PT1910333E (pt)	2005-07-26	2013-08-01	Sanofi Sa	Derivados de isoquinolona substituída com piperidinilo como inibidores da rho-cinase
HRP20110839T1 (hr) *	2005-07-26	2011-12-31	Sanofi	Derivati cikloheksaminizokinolona kao inhibitori rho-kinaze
TW200745101A (en)	2005-09-30	2007-12-16	Organon Nv	9-Azabicyclo[3.3.1]nonane derivatives
TW200738682A (en)	2005-12-08	2007-10-16	Organon Nv	Isoquinoline derivatives
US7618985B2 (en)	2005-12-08	2009-11-17	N.V. Organon	Isoquinoline derivatives
US7893088B2 (en)	2006-08-18	2011-02-22	N.V. Organon	6-substituted isoquinoline derivatives
RU2009128693A (ru)	2006-12-27	2011-02-10	Санофи-Авентис (Fr)	Замещенные производные изохинолина и изохинолинона
KR20090103903A (ko)	2006-12-27	2009-10-01	사노피-아벤티스	사이클로알킬아민 치환된 이소퀴놀론 및 이소퀴놀리논 유도체
BRPI0721180A2 (pt)	2006-12-27	2014-03-18	Sanofi Aventis	Derivados de isoquinolina substituídos com cicloalquilamina
JP5405314B2 (ja)	2006-12-27	2014-02-05	サノフイ	シクロアルキルアミン置換イソキノロン誘導体
RU2468011C2 (ru)	2006-12-27	2012-11-27	Санофи-Авентис	Замещенные циклоалкиламином производные изохинолина и изохинолинона
KR101545533B1 (ko)	2006-12-27	2015-08-19	사노피	치환된 이소퀴놀린 및 Ｒｈｏ-키나아제 억제제로서의 이의 용도
MY150746A (en)	2006-12-27	2014-02-28	Sanofi Aventis	Substituted isoquinoline and isoquinolinone derivatives as inhibitors of rho-kinase

2009
- 2009-06-19 RU RU2011102456/04A patent/RU2538588C2/ru not_active IP Right Cessation
- 2009-06-19 EP EP20090768949 patent/EP2303846B1/en active Active
- 2009-06-19 CN CN200980132930.XA patent/CN102131784B/zh not_active Expired - Fee Related
- 2009-06-19 BR BRPI0914696A patent/BRPI0914696A2/pt not_active IP Right Cessation
- 2009-06-19 AU AU2009262517A patent/AU2009262517B2/en not_active Ceased
- 2009-06-19 SI SI200931226T patent/SI2303846T1/sl unknown
- 2009-06-19 MY MYPI2010005570A patent/MY157330A/en unknown
- 2009-06-19 HU HUE09768949A patent/HUE026617T2/en unknown
- 2009-06-19 HR HRP20150726TT patent/HRP20150726T1/hr unknown
- 2009-06-19 KR KR1020107028887A patent/KR101638326B1/ko not_active Expired - Fee Related
- 2009-06-19 NZ NZ590070A patent/NZ590070A/en not_active IP Right Cessation
- 2009-06-19 PL PL09768949T patent/PL2303846T3/pl unknown
- 2009-06-19 US US13/000,754 patent/US8541449B2/en not_active Expired - Fee Related
- 2009-06-19 CA CA2728137A patent/CA2728137C/en not_active Expired - Fee Related
- 2009-06-19 ES ES09768949.1T patent/ES2541827T3/es active Active
- 2009-06-19 WO PCT/EP2009/004421 patent/WO2009156100A1/en not_active Ceased
- 2009-06-19 PT PT97689491T patent/PT2303846E/pt unknown
- 2009-06-19 PE PE2010001193A patent/PE20110059A1/es not_active Application Discontinuation
- 2009-06-19 MX MX2010013975A patent/MX2010013975A/es active IP Right Grant
- 2009-06-19 DK DK09768949.1T patent/DK2303846T3/en active
- 2009-06-19 JP JP2011515175A patent/JP5713893B2/ja not_active Expired - Fee Related
- 2009-06-22 AR ARP090102285A patent/AR072281A1/es unknown
- 2009-06-22 UY UY0001031925A patent/UY31925A/es not_active Application Discontinuation
- 2009-06-22 TW TW098120767A patent/TWI462907B/zh not_active IP Right Cessation
2010
- 2010-11-12 ZA ZA2010/08119A patent/ZA201008119B/en unknown
- 2010-12-07 CR CR11831A patent/CR11831A/es not_active Application Discontinuation
- 2010-12-17 MA MA33438A patent/MA32400B1/fr unknown
- 2010-12-20 SV SV2010003772A patent/SV2010003772A/es unknown
- 2010-12-20 IL IL210113A patent/IL210113A/en not_active IP Right Cessation
- 2010-12-20 DO DO2010000394A patent/DOP2010000394A/es unknown
- 2010-12-21 CO CO10160331A patent/CO6321250A2/es not_active Application Discontinuation
- 2010-12-22 EC EC2010010705A patent/ECSP10010705A/es unknown

Also Published As

Publication number	Publication date
MA32400B1 (fr)	2011-06-01
HUE026617T2 (en)	2016-06-28
NZ590070A (en)	2012-02-24
SI2303846T1 (sl)	2015-08-31
JP2011525511A (ja)	2011-09-22
RU2538588C2 (ru)	2015-01-10
JP5713893B2 (ja)	2015-05-07
IL210113A (en)	2015-10-29
US8541449B2 (en)	2013-09-24
TW201010978A (en)	2010-03-16
CN102131784A (zh)	2011-07-20
ECSP10010705A (es)	2011-01-31
CR11831A (es)	2011-03-18
AR072281A1 (es)	2010-08-18
BRPI0914696A2 (pt)	2016-10-18
TWI462907B (zh)	2014-12-01
IL210113A0 (en)	2011-02-28
CA2728137A1 (en)	2009-12-30
MY157330A (en)	2016-05-31
DOP2010000394A (es)	2011-01-15
CA2728137C (en)	2016-10-18
HK1158644A1 (en)	2012-07-20
ES2541827T3 (es)	2015-07-27
US20110190341A1 (en)	2011-08-04
ZA201008119B (en)	2011-07-27
KR101638326B1 (ko)	2016-07-12
RU2011102456A (ru)	2012-07-27
CN102131784B (zh)	2014-08-27
MX2010013975A (es)	2011-01-14
EP2303846A1 (en)	2011-04-06
AU2009262517B2 (en)	2014-01-09
HRP20150726T1 (hr)	2015-09-25
CO6321250A2 (es)	2011-09-20
PT2303846E (pt)	2015-09-04
WO2009156100A1 (en)	2009-12-30
UY31925A (es)	2010-01-29
PE20110059A1 (es)	2011-02-15
DK2303846T3 (en)	2015-08-03
EP2303846B1 (en)	2015-04-29
SV2010003772A (es)	2011-03-15
KR20110021922A (ko)	2011-03-04
AU2009262517A1 (en)	2009-12-30

Publication	Publication Date	Title
IL210113A0 (en)	2011-02-28	Substituted isoquinolines and isoquinolinones as rho kinase inhibitors
IL284889A (en)	2021-08-31	Imidazotriazines and imidazopyrimidines as kinase inhibitors
ZA200903554B (en)	2010-05-26	Substituted isoquinolines and their use as rho-kinase inhibitors
IL211549A0 (en)	2011-05-31	Aminotriazolopyridines and their use as kinase inhibitors
ZA201004942B (en)	2011-12-28	Ptrrolopyrazine kinase inhibitors
ZA201100211B (en)	2014-03-26	Kinase inhibitors and methods of use
EP2252293A4 (en)	2015-06-24	KINASEHEMMER AND USE PROCESS
IL212755A0 (en)	2011-07-31	Pyrazinopyrazines and derivatives as kinase inhibitors
IL216511A0 (en)	2012-02-29	Janus kinase inhibitor compounds and methods
IL211693A0 (en)	2011-06-30	Imidazopyridazinecarbonitriles useful as kinase inhibitors
ZA200907777B (en)	2010-07-28	Quinoline derivatives as P13 kinase inhibitors
EP2382210A4 (en)	2012-06-20	INHIBITORS OF PYRIMIDINEDIAMINE KINASE
EP2247185A4 (en)	2012-01-25	INHIBITORS OF TYROSINE KINASE
IL210115A0 (en)	2011-02-28	6-substituted isoquinolines and isoquinolinones
EP2344472A4 (en)	2012-11-28	ISOCHINOLINONDERIVATE
ZA201008120B (en)	2011-08-31	Bi-and polycyclic substituted isoquinoline and isoquinoline derivatives as rho kinase inhibitors
ZA201002885B (en)	2011-07-27	Quinoline derivatives and their use as tyrosine kinase inhibitors
GB0805693D0 (en)	2008-04-30	Combinations of P13-delta and P13-gamma kinase inhibitor compounds